Literature DB >> 23196360

Reproducibility of linear array for human papillomavirus genotyping.

Jill Koshiol1, S Terence Dunn, Joan L Walker, Rosemary E Zuna, Mark Schiffman, Mark E Sherman, Michael A Gold, Richard A Allen, Roy Zhang, Sophia S Wang, Nicolas Wentzensen.   

Abstract

We conducted a Linear Array test/retest analysis using cytologic specimens from 198 women. A total of 67.2% of samples had the same human papillomavirus (HPV) types detected in both tests (type-specific positive agreement was 83.3% overall [Kappa = 0.9] and 86.8% for carcinogenic types [Kappa = 0.92]). Discordance was highest with a low hybridization signal strength. Overall, Linear Array was highly reproducible.

Entities:  

Mesh：

Year:  2012        PMID： 23196360      PMCID： PMC3553882          DOI： 10.1128/JCM.03036-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples.

Authors:  Seung Hun Song; Jin Hwa Hong; San Ha Kwak; Jae Kwan Lee; Mi Kyung Kim
Journal:  J Obstet Gynaecol Res       Date:  2011-12-19       Impact factor: 1.730

2.  DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods.

Authors:  S Terence Dunn; Richard A Allen; Sophia Wang; Joan Walker; Mark Schiffman
Journal:  J Virol Methods       Date:  2007-03-30       Impact factor: 2.014

3.  Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results.

Authors:  Thomas C Wright; Mark H Stoler; Abha Sharma; Guili Zhang; Catherine Behrens; Teresa L Wright
Journal:  Am J Clin Pathol       Date:  2011-10       Impact factor: 2.493

4.  Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Authors:  Philip E Castle; Mark H Stoler; Thomas C Wright; Abha Sharma; Teresa L Wright; Catherine M Behrens
Journal:  Lancet Oncol       Date:  2011-08-22       Impact factor: 41.316

5.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.

Authors:  Hormuzd A Katki; Walter K Kinney; Barbara Fetterman; Thomas Lorey; Nancy E Poitras; Li Cheung; Franklin Demuth; Mark Schiffman; Sholom Wacholder; Philip E Castle
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

6.  Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens.

Authors:  Nicolas Wentzensen; Patti E Gravitt; Rodney Long; Mark Schiffman; S Terence Dunn; J Daniel Carreon; Richard A Allen; Munira Gunja; Rosemary E Zuna; Mark E Sherman; Michael A Gold; Joan L Walker; Sophia S Wang
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

7.  Global proficiency study of human papillomavirus genotyping.

Authors:  Carina Eklund; Tiequn Zhou; Joakim Dillner
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

8.  ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.

Authors:  M Schiffman; M E Adrianza
Journal:  Acta Cytol       Date:  2000 Sep-Oct       Impact factor: 2.319

9.  Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping.

Authors:  Laura Giuliani; Anna Coletti; Kari Syrjänen; Cartesio Favalli; Marco Ciotti
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

Review 10.  Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.

Authors:  Joseph Tota; Salaheddin M Mahmud; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  Sex Health       Date:  2010-09       Impact factor: 2.706
View more
  5 in total

1.  Development of a novel liquid bead array human papillomavirus genotyping assay (PGMY-LX) and comparison with linear array for continuity in longitudinal cohort studies.

Authors:  Sepideh Farhat; Mark E Scott; Yifei Ma; Anna-Barbara Moscicki
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

2.  Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer.

Authors:  Laura Ortega-Cervantes; Adriana Aguilar-Lemarroy; Aurora Elizabeth Rojas-García; Briscia Socorro Barrón-Vivanco; Verónica Vallejo-Ruiz; David Cantú-De León; Yael Yvette Bernal Hernández; Armando Jáuregui-Martínez; Irma Martha Medina-Díaz
Journal:  Int J Health Sci (Qassim)       Date:  2016-07

3.  Sequencing-based genotyping of mixed human papillomavirus infections by use of RipSeq software.

Authors:  Keith D Tardif; Keith E Simmon; Oyvind Kommedal; Michael T Pyne; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

4.  Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Authors:  Carole Fakhry; Amanda L Blackford; Geoff Neuner; Weihong Xiao; Bo Jiang; Amit Agrawal; Maura L Gillison
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

5.  The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma.

Authors:  Paula Roberta Aguiar Pastrez; Vânia Sammartino Mariano; Allini Mafra da Costa; Estela Maria Silva; Cristovam Scapulatempo-Neto; Denise Peixoto Guimarães; Gilberto Fava; Said Abdala Zemi Neto; Emily Montosa Nunes; Laura Sichero; Luisa Lina Villa; Kari Juhani Syrjanen; Adhemar Longatto-Filho
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.